CLARK Prescription Drug Abuse - Misuse Neurobiology Epidemiology EBPs

Recommendations

Info

Past Year Initiates of Specific Illicit <strong>Drug</strong>s among Persons > 12 years old Numbers in Thousands 3,000 2012 2,500 2,398 2,000 1,880 1,500 1,000 500 0 1,427 869 676 639 584 421 166 156 90 Pain Relievers Ecstasy Cocaine LSD Heroin Marijuana Tranquilizers Stimulants Inhalants Sedatives PCP Note: Numbers refer to persons who used a specific drug for the first time in the past year, regardless of whether initiation of other drug use occurred prior to the past year. SAMHSA NSDUH 2013 32
Mean Age at First Use for Specific Illicit <strong>Drug</strong>s among Past Year Initiates Aged 12 to 49 Age in Years 30 25 20 16.6 16.9 17.9 19.0 2012 20.0 20.3 22.1 22.3 23.0 23.6 26.2 15 10 5 0 PCP Inhalants LSD Ecstasy Pain Relievers Tranquilizers Marijuana Cocaine Stimulants Heroin Sedatives SAMHSA NSDUH 2013 33
Page 2 and 3: Prescription Drug Abuse & Misuse: N
Page 4 and 5: Secretary Kathleen Sebelius U.S. De
Page 6 and 7: Prescription Drugs Abuse & Misuse:
Page 8 and 9: Topics Neurobiology Epidemiology EB
Page 10 and 11: Addiction is a Chronic Brain Diseas
Page 12 and 13: Movement Motivation Dopamine Addict
Page 14 and 15: Slide courtesy of NIDA 14
Page 16 and 17: Dopamine & Exogenous Opioids: Hyper
Page 18 and 19: Other Neurotransmitter Systems Scie
Page 20 and 21: Opioid Binding Sites Adapted from N
Page 22 and 23: One Size Does Not Fit All: Addictio
Page 24 and 25: Topics Neurobiology Epidemiology Tr
Page 26 and 27: Past Month Nonmedical Use of Types
Page 28 and 29: Source Where Pain Relievers Were Ob
Page 30 and 31: Past Month and Past Year Heroin Use
Page 34 and 35: Substances for Which Most Recent Tr
Page 36 and 37: Percentage of ED visits involving n
Page 38 and 39: Opioid Related Emergency Department
Page 40 and 41: Topics Neurobiology Epidemiology EB
Page 42 and 43: ROSC: A Way to Better Health for Al
Page 44 and 45: ROSC Framework Provides a coordinat
Page 46 and 47: One Size Does Not Fit All: Evidence
Page 48 and 49: Medication Assisted Treatment MAT i
Page 50 and 51: EBP: Rehabilitation & Therapeutic M
Page 52 and 53: EB Treatment is Complicated: Interd
Page 54 and 55: EBP Opioid Overdose Toolkit Over 23
Page 56 and 57: EBP Treatment Protocols and KAP Key
Page 58 and 59: EBP Consensus Guidelines (in proces
Page 60 and 61: EBP Literature Reviews September 20
Page 62 and 63: EBP: SBIRT’s Return-on-Investment
Page 64 and 65: SAMHSA Block Grants (Dollars in Tho
Page 66 and 67: Implementation of National Action P
Page 68 and 69: Key Takeaways of National Action Pl
Page 70 and 71: “Advancing Access to Addiction Me
Page 72: THANK YOU! Westley.Clark@samhsa.hhs

CLARK Prescription Drug Abuse - Misuse Neurobiology Epidemiology EBPs

Create successful ePaper yourself

Delete template?

Save as template?